This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04596/identifier/pdb/
n10http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB04596/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB04596/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04596/identifier/drugbank/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04596
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB04596 n10:DB04596
dcterms:title
4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE-(1->4)-BETA-D-GLUCURONIC ACID
adms:identifier
n8:6602345 n9:46509174 n11:DB04596 n12:46D
n3:IUPAC-Name
n4:271B41BF-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B41C5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B41C4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B41C1-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B41C2-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B41C3-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B41BD-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B41BE-363D-11E5-9242-09173F13E4C5 n4:271B41BB-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B41BC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B41CB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B41CC-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B41C6-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B41C7-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B41C9-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B41C8-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B41CA-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B41D1-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B41D3-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B41D4-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B41D0-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B41CF-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B41D2-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B41C0-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B41CD-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B41CE-363D-11E5-9242-09173F13E4C5